Two Sigma Investments, LP Compugen LTD Transaction History

Two Sigma Investments, LP

$41.6 Billion
Q4 2024

A detailed history of Two Sigma Investments, LP transactions in Compugen LTD stock. As of the latest transaction made, Two Sigma Investments, LP holds 54,042 shares of CGEN stock, worth $113,488. This represents 0.0% of its overall portfolio holdings.

Number of Shares

54,042

Previous 74,183 27.15%

Holding current value

$113,488

Previous $134,000 38.81%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$1.41 - $1.93 $28,398 - $38,872	-20,141 Reduced 27.15%	54,042 $82,000
Q3 2024 Nov 14, 2024	BUY	$1.56 - $2.1 $84,077 - $113,181	53,896 Added 265.67%	74,183 $134,000
Q2 2024 Aug 14, 2024	SELL	$1.68 - $2.52 $137,012 - $205,518	-81,555 Reduced 80.08%	20,287 $34,000
Q1 2024 May 15, 2024	SELL	$1.75 - $2.95 $48,286 - $81,396	-27,592 Reduced 21.32%	101,842 $262,000
Q4 2023 Feb 14, 2024	SELL	$0.53 - $2.0 $87,287 - $329,388	-164,694 Reduced 55.99%	129,434 $256,000
Q3 2023 Nov 14, 2023	SELL	$0.88 - $1.31 $87,258 - $129,895	-99,157 Reduced 25.21%	294,128 $273,000
Q2 2023 Aug 14, 2023	SELL	$0.57 - $1.38 $135,470 - $327,981	-237,668 Reduced 37.67%	393,285 $448,000
Q1 2023 May 15, 2023	SELL	$0.68 - $1.11 $135,111 - $220,550	-198,694 Reduced 23.95%	630,953 $441,000
Q4 2022 Feb 14, 2023	SELL	$0.58 - $1.2 $399,278 - $826,094	-688,412 Reduced 45.35%	829,647 $597,000
Q3 2022 Nov 14, 2022	BUY	$0.66 - $2.32 $668,423 - $2.35 Million	1,012,763 Added 200.43%	1,518,059 $997,000
Q2 2022 Aug 15, 2022	BUY	$1.57 - $3.33 $276,346 - $586,136	176,017 Added 53.46%	505,296 $935,000
Q1 2022 May 16, 2022	SELL	$2.76 - $4.64 $217,896 - $366,318	-78,948 Reduced 19.34%	329,279 $1.06 Million
Q4 2021 Feb 14, 2022	BUY	$4.09 - $7.16 $197,301 - $345,398	48,240 Added 13.4%	408,227 $1.76 Million
Q3 2021 Nov 15, 2021	BUY	$5.8 - $8.02 $1.99 Million - $2.75 Million	343,435 Added 2074.89%	359,987 $2.15 Million
Q2 2021 Aug 16, 2021	SELL	$6.87 - $9.16 $1.28 Million - $1.7 Million	-185,671 Reduced 91.81%	16,552 $137,000
Q1 2021 May 17, 2021	BUY	$7.67 - $13.77 $1.55 Million - $2.78 Million	202,223 New	202,223 $1.74 Million
Q3 2018 Nov 14, 2018	SELL	$3.0 - $4.05 $54,084 - $73,013	-18,028 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$3.15 - $4.7 $56,788 - $84,731	18,028 New	18,028 $59,000

Others Institutions Holding CGEN

# of Institutions

Shares Held

13.4M

Call Options Held

44.9K

Put Options Held

8.1K

View Full List

About COMPUGEN LTD

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $182M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

More about CGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Compugen LTD Transaction History